Logo

Fluidigm Advanta Sample ID Genotyping Panel

Jun 05, 2018

Fluidigm has launched the Advanta Sample ID Genotyping Panel for the identification and quality assessment of human samples and cell lines in disease research. Developed for use with the Biomark HD system, the Advanta panel enables laboratories to accurately detect a unique genetic fingerprint from samples at each stage of their journey. The panel design contains 96 different SNP variants, including 80 synonymous human variants located in exonic regions of the genome; 10 quality assessment variants; and six gender-confirming variants. New targets for specific sample populations also can be added to customize the panel based on specific study goals, Fluidigm noted.


Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.